Haemonetics inks $510M Cardiva takeover to expand hospital business

Haemonetics has struck a deal to buy Cardiva Medical for $510 million, giving it control of vascular closure systems.

Cardiva sells two devices, Vascade and Vascade MVP, that use collagen plugs to close the vascular access sites created in catheter-based coronary, peripheral and electrophysiology procedures.